Maurizio Chiriva-Internati
Chief Executive Officer bei Kiromic, Inc.
Profil
Maurizio Chiriva-Internati is the founder of Kiromic Biopharma, Inc. (founded in 2006) and Kiromic, Inc. (founded in 2013).
He held the titles of Chairman, President & Chief Executive Officer at Kiromic Biopharma, Inc. and Director, Chief Executive & Scientific Officer at Kiromic, Inc. He is currently an Associate Professor at The University of Texas M.D.
Anderson Cancer Center since 2019.
He was previously an Associate Professor at Texas Tech University Health Sciences Center from 2013 to 2017.
He holds a doctorate degree from The University of Nottingham and the University of Milan.
Aktive Positionen von Maurizio Chiriva-Internati
| Unternehmen | Position | Beginn |
|---|---|---|
Kiromic, Inc.
 Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Chief Executive Officer | 01.01.2013 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.08.2019 |
Ehemalige bekannte Positionen von Maurizio Chiriva-Internati
| Unternehmen | Position | Ende |
|---|---|---|
| KIROMIC BIOPHARMA, INC. | Chief Executive Officer | 27.01.2022 |
| Texas Tech University Health Sciences Center | Corporate Officer/Principal | 01.06.2017 |
Ausbildung von Maurizio Chiriva-Internati
| The University of Nottingham | Doctorate Degree |
| University of Milan | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Kiromic, Inc.
Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Health Services |
